Virology Market Scope And Analysis

Report Code : TIPRE00006886
Category : Life Sciences

Status : Published
No. of Pages : 227

Buy Now

Virology Market Scope, Analysis, and Trends by 2028

Buy Now

Virology Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 4.11 Billion
Market Size by 2028	US$ 5.28 Billion
Global CAGR (2021 - 2028)	3.6%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Type Diagnostic Test Viral Infection Controlling Techniques Antiviral Therapeutics Interferons By Application Skin and Soft Tissue Infections Respiratory Tract Infections GI Tract Infections Sexually Transmitted Diseases Urinary Tract Infection By End User Hospitals Diagnostic Laboratories Pharmaceutical and Biotechnological Companies Research and Academic Institutes
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Johnson And Johnson Services Inc F HOFFMANN LA ROCHE LTD THERMO FISHER SCIENTIFIC INC QIAGEN Illumina Inc Siemens AG Glaxosmithkline Plc Abbvie Inc

Type-Based Insights

Based on type, the virology market is further segmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, the diagnostic test segment is expected to hold the largest share of the market, and viral infection controlling techniques segment is estimated to register the highest CAGR during 2021–2028.

Application-Based Insights

Based on application, the market is segmented into skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infection, and others. In 2021, the respiratory tract infections segment is estimated to hold the largest share of the market, and it is expected to register the highest CAGR during 2021–2028.
Companies operating in the virology market emphasize on adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Virology Market – Segmentation

By Type

Diagnostic Test
- DNA Virus Testing
- RNA Virus Testing
- Others
Viral Infection Controlling Techniques
- Active Prophylaxis
- Passive Prophylaxis
Antiviral Therapeutics
- Virucidal Agents
- Antiviral Agents
- Immunomodulators
Interferons

By Application

Skin and Soft Tissue Infections
Respiratory Tract Infections
GI Tract Infections
Sexually Transmitted Diseases
Urinary Tract Infections
Others

By End User

Hospitals
Diagnostic Laboratories
Pharmaceutical and Biotechnological Companies
Research and Academic Institutes

By Geography

North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America
- Brazil
- Argentina
- Rest of SCAM

Company Profiles

Abbott
Johnson & Johnson Services, Inc.
F. Hoffmann-LA Roche Ltd.
Thermo Fisher Scientific, Inc.
Qiagen
Illumina, Inc.
Siemens AG
GlaxoSmithKline Plc
Gilead Sciences, Inc.
AbbVie, Inc.pyright names given on respective websites.